Developing new treatments for age-related osteoporosis.
Official title: Optimizing Small Molecule Mechanomimetics to Treat Age-related Osteoporosis.
Funded at Oak Ridge Therapeutic Discovery (Orrxd), LLC · NIH-10807685 · Data updated 2026-11-12
This study is exploring new treatments for senile osteoporosis by looking at how certain proteins in bone cells respond to stress, with the goal of developing small drugs that can help strengthen bones and reduce fat in the bone marrow.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oak Ridge Therapeutic Discovery (Orrxd), LLC NIH-funded |
| Lab location | 1 site (Memphis, United States) |
| Project start | September 30, 2023 |
| Project end | August 31, 2025 |
| Funding year | 2023 |
| Award (this year) | $249,658 |
| NIH project number | 1R41AG082524-01A1 |
| Project ID | NIH-10807685 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older adults experiencing symptoms of osteoporosis or those at risk of developing the condition.
✕Less likely to help
Patients who are not experiencing age-related bone loss or those with other underlying conditions affecting bone health may not benefit from this research.
What this research studies
This research focuses on finding new ways to treat senile osteoporosis, a condition where bones weaken as people age. The approach involves understanding how certain proteins in bone cells act as sensors for mechanical stress, which is crucial for bone health. By using advanced drug design techniques, the researchers aim to create small molecules that can enhance bone formation and reduce fat accumulation in the bone marrow. These compounds have shown promise in laboratory tests by stimulating bone-building cells and inhibiting fat cell formation.
Why it matters
Potential benefit: If successful, this research could lead to effective treatments that improve bone density and reduce the risk of fractures in older adults.
How similar studies have gone: Previous research has shown success in developing treatments targeting bone mechanosensing, indicating a promising avenue for this approach.
Where this research is happening
-
Oak Ridge Therapeutic Discovery (Orrxd), LLC
Memphis, United States Active
Researchers
- Principal investigator: Quarles, L Darryl — Oak Ridge Therapeutic Discovery (Orrxd), LLC
- Study coordinator: Quarles, L Darryl
Related research
Other NIH-funded projects on the same topics.
-
Or olive-oil derived compound to prevent bone loss in women
A safe, orally taken nutraceutical may help prevent osteoporosis in adult women by supporting bone formation and reducing bone loss.
-
When to stop, switch, or pause long-term osteoporosis medicines for older adults
This project looks at whether stopping, switching, or taking breaks from long-term osteoporosis drugs changes fracture risk and side effects for older adults.
-
Cortical Bone Mechanics Technology to better screen for osteoporosis
A new noninvasive test called CBMT uses ulnar flexural rigidity to predict fracture risk better than standard bone density tests, helping adults who may be at risk for osteoporosis.
-
Gene therapy for osteoporosis linked to ALDH2 deficiency in postmenopausal East Asian women
A gene therapy approach is being developed to reduce osteoporosis risk in postmenopausal East Asian women who have ALDH2 deficiency and drink alcohol.
-
Metabolomics clues to osteoporosis risk in diverse populations
A study using small molecules in blood samples to understand osteoporosis risk, with a focus on aging, ethnicity, and sex differences.
-
Single-Cell Study of Bone Cells to Understand Osteoporosis
Researchers will study individual bone-related cells from people to uncover why aging leads to weaker bones and higher fracture risk.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.